Efficacy of cell-derived quadrivalent influenza vaccine (Flucelvax
Quadrivalent) in children and adolescents from 2 years to 18 years old; Influenza Disease Burden and Vaccine Impact Estimates, 2019-20 Season; End-of-Season Estimates of 2019–20 Seasonal Influenza Vaccine Effectiveness against Medically Attended Influenza from three U.S. Networks; Updates and WG Considerations

This video can also be viewed at